• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION PRISMAFLEX SETS (TPE); SEPARATOR FOR THERAPEUTIC PURPOSES, MEMBRANE AUTOMATED BLOOD CELL/PLASMA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION PRISMAFLEX SETS (TPE); SEPARATOR FOR THERAPEUTIC PURPOSES, MEMBRANE AUTOMATED BLOOD CELL/PLASMA Back to Search Results
Catalog Number 107144
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943); Swelling/ Edema (4577)
Event Date 06/27/2022
Event Type  Injury  
Manufacturer Narrative
(b)(6).Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that during the first cycle of therapeutic plasma exchange treatment (tpe) using a prismaflex tpe2000 set, the patient became cold; however, treatment was completed without issues.During the second cycle of tpe, the patient became cold again, experienced ¿itchiness¿ and showed signs of hypocalcemia with a ¿funny feeling in the mouth.The patient received ¿2 x2.2mmol¿ of calcium gluconate as a slow push, while the blood was returned.The patient also experienced swelling around the eyes, hives and redness to the eyes and chin.The patient was administered 100mg intravenous hydrocortisone, oral loratadine and intramuscular injection of adrenaline (500mcg) for the events.No additional information is available.
 
Manufacturer Narrative
Correction: removal of information in section f related to importer - the follow-up #1 report inadvertently included information in f7: report type and f7: follow - up #.This information is being removed as this mdr is a manufacturer mdr (and not an importer mdr).Should additional relevant information become available, a supplemental report will be submitted.
 
Manufacturer Narrative
A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX SETS (TPE)
Type of Device
SEPARATOR FOR THERAPEUTIC PURPOSES, MEMBRANE AUTOMATED BLOOD CELL/PLASMA
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - MEYZIEU
7, av lionel terray, b.p. 126
meyzieu cedex rhone 69883
FR   69883
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 
2242702068
MDR Report Key15093656
MDR Text Key296481173
Report Number8010182-2022-00212
Device Sequence Number1
Product Code MDP
UDI-Device Identifier07332414069339
UDI-Public(01)07332414069339
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 08/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/25/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number107144
Device Lot Number21K0112CA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/12/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ALBUMIN; FFP
Patient Outcome(s) Required Intervention;
Patient Age33 YR
Patient SexFemale
-
-